
Jan 7 (Reuters) - The United Arab Emirates' drug regulator has recalled certain Nestle infant formula products after the company recalled specific batches over a potential toxin risk, the state news agency (WAM) reported on Wednesday.
The Emirates Drug Establishment said no illness or adverse events linked to the affected batches have been reported or confirmed, WAM added.
The Qatari ministry of public health has also warned consumers against using specific batches of Nestle infant formula products over suspected contamination with cereulide toxin, the Qatari state news agency reported.
Nestle said late on Monday it was recalling specific batches of its SMA infant formula and follow-on formula due to the potential presence of a toxin that could lead to nausea, vomiting and abdominal cramps.
(Reporting by Ahmed Tolba and Yomna Ehab in Cairo; Editing by Chris Reese and David Gregorio)
latest_posts
- 1
Several killed in Ukraine and Russia after cross-border attacks - 2
NASA counts down for first crewed lunar mission in half a century - 3
After toilet and email issues, Artemis II astronauts fire engine to head for the moon - 4
The Meaning of Breaking the Pen's Nib in Death penalties - 5
Former ‘Dancing with the Stars’ Pro Survives Plane Crash at LaGuardia That Left 2 Pilots Dead
Senegal limits foreign trips for officials as the fallout from Iran war deepens
New trailer for 'Bridgerton' Season 4 teases Benedict's love story: Watch it here
Far-right AfD invited back to Munich Security Conference in 2026
Select Your Definitive Pizza Decision
OpenAI launches ChatGPT Health to connect medical records, wellness apps
Amid growing bipartisan scrutiny of Pete Hegseth, Trump says he 'wouldn't have wanted … a second strike' on alleged Venezuelan drug boat survivors
Picking the Right Doctor prescribed Medication Inclusion in Senior Protection.
Hostages as leverage: Iran's secret demand aimed at crippling Israel's agriculture
How AI fixed the James Webb Space Telescope's blurry vision












